Bariatric Surgery: Effects on the Metabolic Complications of Obesity

Peter Clifton

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)


    Bariatric surgery is increasing at an enormous rate in all countries but the indications for the operation on the basis of metabolic derangements are not clear, as only one controlled randomized trial specifically for a comorbidity has been performed. Thus, it is not clear if bariatric surgery should be offered to all obese patients with long standing type 2 diabetes or poorly controlled hypertension or hypertriglyceridemia, even though these conditions clearly respond in most patients to bariatric surgery and weight loss. It would appear that patients with early type 2 diabetes with reasonable control and a greater body mass index gain more benefit from the operation. More randomized trials are required.

    Original languageEnglish
    Pages (from-to)95-100
    Number of pages6
    JournalCurrent Atherosclerosis Reports
    Issue number2
    Publication statusPublished - Apr 2012


    • Dyslipidemia
    • Gastric band
    • Gastric bypass
    • HDL
    • Hypertension
    • LAGB
    • LDL
    • Mortality
    • RYGB
    • Sleep apnea
    • TG
    • Type 2 diabetes


    Dive into the research topics of 'Bariatric Surgery: Effects on the Metabolic Complications of Obesity'. Together they form a unique fingerprint.

    Cite this